Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Internal Medicine Japan
    Interventional Research Studies with Elranatamab
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Research in Ulcerative Colitis (UC) 2024
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey
    Advances in the Management of Ulcerative Colitis (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Research in Ulcerative Colitis (UC) 2024
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Oncology Japan
    Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
    Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
    Release Date:
    Partner: Sumitomo Pharma
    Review Process: Pfizer Internal
    Education Oncology USA
    Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
    Release Date:
    Partner: American College of Emergency Physicians (ACEP)
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Hospital Benin, Congo, The Democratic Republic